Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Molena

Showing results (221-230 of 264) with videos related to

Pageof 27
Sort By:
BJS Open|January 18, 2022
Primary lung cancer in women after previous breast cancerTamar B Nobel, Rebecca A Carr, Raul Caso, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 24, 2024
High-risk features associated with recurrence in stage I lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Stijn Vanstraelen, et al.
JTO Clinical and Research Reports|July 21, 2022
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term OutcomesJennie K Choe, Amy Zhu, Alexander J Byun, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 7, 2025
Surgical Outcomes Using Three-Dimensional Image Simulation for Segmentectomy Planning in Patients with Stage IA1-2 Non-Small Cell Lung CancerStella T Tsui, Kay See Tan, Junting Zheng, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2025
Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung CancerRaul Caso, Nanruoyi Zhou, Matthew Skovgard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2026
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancersNanruoyi Zhou, Stella Tsui, Nicolas Toumbacaris, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancerHarry B Lengel, Junting Zheng, Kay See Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2020
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung AdenocarcinomaRaul Caso, Francisco Sanchez-Vega, Kay See Tan, et al.
Pageof 27

Showing results (221-230 of 264) with videos related to

Sort By:
Pageof 27
BJS Open|January 18, 2022
Primary lung cancer in women after previous breast cancerTamar B Nobel, Rebecca A Carr, Raul Caso, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 24, 2024
High-risk features associated with recurrence in stage I lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Stijn Vanstraelen, et al.
JTO Clinical and Research Reports|July 21, 2022
Brief Report: Contralateral Lobectomy for Second Primary NSCLC: Perioperative and Long-Term OutcomesJennie K Choe, Amy Zhu, Alexander J Byun, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 7, 2025
Surgical Outcomes Using Three-Dimensional Image Simulation for Segmentectomy Planning in Patients with Stage IA1-2 Non-Small Cell Lung CancerStella T Tsui, Kay See Tan, Junting Zheng, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 31, 2025
Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung CancerRaul Caso, Nanruoyi Zhou, Matthew Skovgard, et al.
Lung Cancer (Amsterdam, Netherlands)|April 20, 2026
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancersNanruoyi Zhou, Stella Tsui, Nicolas Toumbacaris, et al.
Annals of Surgery|August 13, 2021
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal AdenocarcinomaRebecca A Carr, Meier Hsu, Caitlin A Harrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2022
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal AdenocarcinomaSmita Sihag, Samuel C Nussenzweig, Henry S Walch, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2022
Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non-small cell lung cancerHarry B Lengel, Junting Zheng, Kay See Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 14, 2020
The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung AdenocarcinomaRaul Caso, Francisco Sanchez-Vega, Kay See Tan, et al.
Pageof 27